Detalhe da pesquisa
1.
Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
Infect Immun
; 82(9): 3979-85, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25024362
2.
Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
BMC Infect Dis
; 11: 26, 2011 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21269435
3.
Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.
Front Immunol
; 9: 915, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29867930
4.
Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy.
Vaccine
; 31(5): 813-9, 2013 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23228811